NDATOPICALGEL
Approved
Jun 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
5/8 — Partial
DIFFERIN (adapalene) by Galderma is protein. First approved in 2007.
Drug data last refreshed 48m ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DIFFERIN (adapalene) is a topical retinoid gel approved for acne treatment that modulates cellular differentiation, keratinization, and inflammatory processes. The exact mechanism linking these biochemical effects to acne efficacy remains incompletely understood. It is administered topically as a first-line therapy for patients with mild-to-moderate acne vulgaris.
$0.094BPart D
LOE ApproachingProduct approaching loss of exclusivity signals transition from growth-focused commercial teams to defensive positioning and cost optimization efforts.
Mechanism of Action
protein. Biochemical and pharmacological profile studies have demonstrated that adapalene is a modulator of cellular differentiation, keratinization, and inflammatory processes. However, the significance of these findings with regard to the mechanism of action of adapalene for the treatment of acne…
Pharmacologic Class:
Retinoid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris
Started Oct 2025
200 enrolled
Acne Vulgaris
"A Comparative Clinical Evaluation of the Efficacy of Topical Adapalene, Benzoyl Peroxide Gel, Oral Lactobacillus Rhamnosus, D-chiro-inositol, Inulin Capsule, and Their Fixed Combination in Mild to Moderate Acne Vulgaris Patients."
Started Feb 2022
59 enrolled
Acne Vulgaris
Performance of Masimo MightySat Pulse Oximeter in Differing Levels of Skin Pigmentation
Started Oct 2021
88 enrolled
Healthy
Clinical Endpoint Bioequivalence Study of Adapalene Gel 0.1%
Started Jul 2020
0Acne Vulgaris
A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.
Started Sep 2019
446 enrolled
Acne Vulgaris
Worked on DIFFERIN at Galderma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.